Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections (NCT06695585)
Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections: a Prospective Randomized Superiority Trial
🩺 Plain-English Summary (8th-Grade Level)
The purpose of our study is to evaluate the efficacy and safety of different volumes of bladder-numbing medication for pain relief at the time of office bladder Botox injections. This is a randomized prospective, double-blind superiority trial comparing 200 ml 2% lidocaine versus 30 ml 2% lidocaine for office Botox injections.
Who can join: Review the eligibility criteria below.
Location: University of Louisville Division of Urogynecology and Reconstructive Pelvic Surgery — Louisville, Kentucky
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Louisville Division of Urogynecology and Reconstructive Pelvic Surgery — Louisville, Kentucky
📞 Contact the Study Coordinator
Phone: (502) 588-7660
Email: laurel.carbone@louisvill.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overactive Bladder
- Reduced-dose Botox for Urgency Incontinence Among Elder Females — Birmingham, Alabama
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections — Cincinnati, Ohio
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease — Decatur, Georgia
- Add-On ZIDA Sock Therapy for Overactive Bladder — Charleston, South Carolina
- Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder — Bethesda, Maryland
Explore by condition: All Overactive Bladder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.